Pediatrix Medical [MD] vs Astrana Health [ASTH] Detailed Stock Comparison

Pediatrix Medical Group, Inc.

NYSE
Loading...

Astrana Health Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Pediatrix Medical Group, Inc. wins in 15 metrics, Astrana Health Inc. wins in 5 metrics, with 0 ties. Pediatrix Medical Group, Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Pediatrix Medical Group, Inc. Astrana Health Inc. Better
P/E Ratio (TTM) 11.88 73.30 Pediatrix Medical Group, Inc.
Price-to-Book Ratio 2.16 2.12 Astrana Health Inc.
Debt-to-Equity Ratio 73.29 193.10 Pediatrix Medical Group, Inc.
PEG Ratio 9.90 -0.41 Pediatrix Medical Group, Inc.
EV/EBITDA 7.92 14.57 Pediatrix Medical Group, Inc.
Profit Margin (TTM) 8.64% 0.71% Pediatrix Medical Group, Inc.
Operating Margin (TTM) 11.07% 1.85% Pediatrix Medical Group, Inc.
EBITDA Margin (TTM) 11.07% 1.85% Pediatrix Medical Group, Inc.
Return on Equity 20.28% 4.49% Pediatrix Medical Group, Inc.
Return on Assets (TTM) 6.57% 3.43% Pediatrix Medical Group, Inc.
Free Cash Flow (TTM) $252.63M $104.49M Pediatrix Medical Group, Inc.
1-Year Return 73.57% 49.98% Pediatrix Medical Group, Inc.
Price-to-Sales Ratio (TTM) 1.00 0.59 Astrana Health Inc.
Enterprise Value $2.00B $2.10B Astrana Health Inc.
EV/Revenue Ratio 1.05 0.66 Astrana Health Inc.
Gross Profit Margin (TTM) 25.51% 10.00% Pediatrix Medical Group, Inc.
Revenue per Share (TTM) $23 $65 Astrana Health Inc.
Earnings per Share (Diluted) $1.94 $0.46 Pediatrix Medical Group, Inc.
Beta (Stock Volatility) 0.72 0.77 Pediatrix Medical Group, Inc.
Short % of Float 6.00% 8.35% Pediatrix Medical Group, Inc.

Pediatrix Medical Group, Inc. vs Astrana Health Inc. Stock Performance Analysis

Loading Price Chart...

MD
ASTH

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Pediatrix Medical Group, Inc.0.29%8.46%8.36%25.04%7.40%14.47%
Astrana Health Inc.-0.62%-0.03%0.31%56.02%72.11%52.18%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Pediatrix Medical Group, Inc.73.57%75.20%-20.69%-64.71%-31.34%9.12%
Astrana Health Inc.49.98%24.10%-27.77%642.69%657.25%657.25%

Performance & Financial Health Analysis: Pediatrix Medical Group, Inc. vs Astrana Health Inc.

MetricMDASTH
Market Information
Market Cap i$1.91B$1.88B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i510,889497,178
90 Day Avg. Volume i755,756435,283
Last Close$24.37$38.38
52 Week Range$11.84 - $24.99$18.08 - $40.13
% from 52W High-2.48%-4.36%
All-Time High$86.09 (Aug 17, 2015)$133.23 (Nov 15, 2021)
% from All-Time High-71.69%-71.19%
Growth Metrics
Quarterly Revenue Growth-0.02%0.43%
Quarterly Earnings Growth0.11%0.43%
Financial Health
Profit Margin (TTM) i0.09%0.01%
Operating Margin (TTM) i0.11%0.02%
Return on Equity (TTM) i0.20%0.04%
Debt to Equity (MRQ) i73.29193.10
Cash & Liquidity
Book Value per Share (MRQ)$10.68$15.94
Cash per Share (MRQ)$6.16$8.68
Operating Cash Flow (TTM) i$271.09M$114.60M
Levered Free Cash Flow (TTM) i$190.33M$227.95M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Pediatrix Medical Group, Inc. vs Astrana Health Inc.

MetricMD (Apr 26, 2026)ASTH (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i11.8873.30
Forward P/E i9.9010.50
PEG Ratio i9.90-0.41
Price to Sales (TTM) i1.000.59
Price to Book (MRQ) i2.162.12
Market Capitalization
Market Capitalization i$1.91B$1.88B
Enterprise Value i$2.00B$2.10B
Enterprise Value Metrics
Enterprise to Revenue i1.050.66
Enterprise to EBITDA i7.9214.57
Risk & Other Metrics
Beta i0.720.77
Book Value per Share (MRQ) i$10.68$15.94

Financial Statements Comparison: Pediatrix Medical Group, Inc. vs Astrana Health Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMD (2025)ASTH (2025)
Revenue/Sales i1.91B3.18B
Cost of Goods Sold i1.42B2.84B
COGS % of Revenue i74.2%89.3%
Gross Profit i493.70M341.53M
Gross Margin i25.8%10.7%
Research & Development iN/AN/A
Operating Income (EBIT) i231.09M78.53M
Operating Margin i12.1%2.5%
EBITDA i256.55M135.35M
EBITDA Margin i13.4%4.3%
Pre-Tax Income i216.43M39.61M
Pre-Tax Income % of Revenue i11.3%1.2%
Income Tax i51.04M15.53M
Income Tax % of Revenue i2.7%0.5%
Net Income (Profit) i165.39M24.08M
Profit Margin i8.6%0.8%

Balance Sheet & Liquidity Metrics

MetricMD (2025)ASTH (2025)
Cash & Equivalents i375.24M429.47M
Total Current Assets i763.51M863.31M
Total Current Assets % of Revenue i39.9%27.1%
Total Current Liabilities i458.91M615.27M
Total Current Liabilities % of Revenue i24.0%19.3%
Long-Term Debt i596.22M1.02B
Long-Term Debt % of Revenue i31.2%32.1%
Total Shareholders Equity i865.85M558.33M
Retained Earnings i-83.15M308.38M
Retained Earnings % of Revenue i-4.3%9.7%
Property, Plant & Equipment i195.53M35.74M

Cash Flow Statement Comparison

MetricMD (2025)ASTH (2025)
Operating Cash Flow i270.23M109.88M
Operating Cash Flow % of Revenue i14.1%3.5%
Capital Expenditures i-18.46M-10.11M
Free Cash Flow i252.63M104.49M
FCF Margin i13.2%3.3%
Debt Repayment i-20.75M-495.29M
Common Stock Repurchase i-86.68M-15.43M

Short Interest & Institutional Ownership Analysis

MetricMDASTH
Shares Short i3.53M2.68M
Short Ratio i3.776.86
Short % of Float i6.00%8.35%
Shares Outstanding i82.98M48.89M
Float Shares i79.95M44.36M
% Held by Insiders i2.31%20.32%
% Held by Institutions i106.63%52.52%
% Held by Public i-8.94%27.16%

Dividend Analysis & Yield Comparison: Pediatrix Medical Group, Inc. vs Astrana Health Inc.

MetricMDASTH
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A